hepatocellular carcinoma


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for hepatocellular carcinoma

carcinoma of the liver

References in periodicals archive ?
In the 7MM, GlobalData epidemiologists forecast that the diagnosed incident cases of Hepatocellular carcinoma (HCC) will increase from 103,308 cases in 2014 to 123,658 cases in 2024 at an Annual Growth Rate (AGR) of 1.
Non-viral factors contributing to hepatocellular carcinoma.
Radioembolisation with yttrium-90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
We also found that the interethnic differences in the prevalence of diabetes were consistent with the pattern of hepatocellular carcinoma incidence observed across ethnicities: Ethnic groups with a high prevalence of diabetes also have high hepatocellular carcinoma rates, and those with a lower prevalence of diabetes have lower hepatocellular carcinoma rates," Setiawan said.
Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation.
A, Photomicrograph shows well-demarcated areas of steatohepatitic hepatocellular carcinoma (SH-HCC) (left side) in an otherwise welldifferentiated trabecular HCC (right side).
A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.
In Europe, Nexavar is approved for the treatment of hepatocellular carcinoma and for the treatment of patients with advanced renal cell carcinoma (RCC) who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
The distinction between well-differentiated hepatocellular carcinoma and hepatocellular adenoma is also difficult [3].
The role of immune system in the control of Hepatocellular carcinoma.
SM-11355 is now under phase II development in Japan as hepatic arterial injection chemotherapy in treating hepatocellular carcinoma.
1) Hepatitis C is the leading cause in Japan of chronic liver disease, cirrhosis, and hepatocellular carcinoma, which is associated with more than 30,000 deaths there annually.
Most of the working group, nevertheless, considered the evidence to be limited, based on the interpretation of hepatoblastoma being a variant of hepatocellular carcinoma.
7 million Americans have chronic hepatitis C virus (HCV) infection and are at risk for HCV-related chronic liver disease and hepatocellular carcinoma (HCC).
Hepatocellular carcinoma is common worldwide but relatively rare in the United States, where only 13,000 new cases are diagnosed each year.
Full browser ?